annual working capital:
$215.95M-$222.92M(-50.79%)Summary
- As of today (July 1, 2025), TVTX annual working capital is $215.95 million, with the most recent change of -$222.92 million (-50.79%) on December 31, 2024.
- During the last 3 years, TVTX annual working capital has fallen by -$242.79 million (-52.93%).
- TVTX annual working capital is now -52.93% below its all-time high of $458.74 million, reached on December 31, 2021.
Performance
TVTX Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$191.71M-$24.24M(-11.22%)Summary
- As of today (July 1, 2025), TVTX quarterly working capital is $191.71 million, with the most recent change of -$24.24 million (-11.22%) on March 31, 2025.
- Over the past year, TVTX quarterly working capital has dropped by -$116.13 million (-37.72%).
- TVTX quarterly working capital is now -64.94% below its all-time high of $546.80 million, reached on September 30, 2023.
Performance
TVTX quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
TVTX Working capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -50.8% | -37.7% |
3 y3 years | -52.9% | -62.5% |
5 y5 years | -35.3% | -43.4% |
TVTX Working capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -52.9% | at low | -64.9% | +42.3% |
5 y | 5-year | -52.9% | at low | -64.9% | +42.3% |
alltime | all time | -52.9% | +407.6% | -64.9% | +279.2% |
TVTX Working capital History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $191.71M(-11.2%) |
Dec 2024 | $215.95M(-50.8%) | $215.95M(+60.3%) |
Sep 2024 | - | $134.70M(-45.6%) |
Jun 2024 | - | $247.71M(-19.5%) |
Mar 2024 | - | $307.85M(-29.9%) |
Dec 2023 | $438.87M(+27.5%) | $438.87M(-19.7%) |
Sep 2023 | - | $546.80M(+34.6%) |
Jun 2023 | - | $406.34M(-14.3%) |
Mar 2023 | - | $474.26M(+37.8%) |
Dec 2022 | $344.27M(-25.0%) | $344.27M(-14.7%) |
Sep 2022 | - | $403.81M(-12.6%) |
Jun 2022 | - | $462.29M(-9.6%) |
Mar 2022 | - | $511.62M(+11.5%) |
Dec 2021 | $458.74M(+44.4%) | $458.74M(-1.5%) |
Sep 2021 | - | $465.92M(+2.9%) |
Jun 2021 | - | $452.82M(-5.7%) |
Mar 2021 | - | $480.03M(+51.1%) |
Dec 2020 | $317.75M(-4.8%) | $317.75M(-24.8%) |
Sep 2020 | - | $422.26M(-3.1%) |
Jun 2020 | - | $435.63M(+28.7%) |
Mar 2020 | - | $338.54M(+1.5%) |
Dec 2019 | $333.62M(-14.7%) | $333.62M(-5.1%) |
Sep 2019 | - | $351.70M(-4.0%) |
Jun 2019 | - | $366.43M(-1.3%) |
Mar 2019 | - | $371.44M(-5.0%) |
Dec 2018 | $391.06M(+62.8%) | $391.06M(-3.0%) |
Sep 2018 | - | $403.12M(+129.8%) |
Jun 2018 | - | $175.42M(-23.8%) |
Mar 2018 | - | $230.28M(-4.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2017 | $240.14M(-3.6%) | $240.14M(-0.5%) |
Sep 2017 | - | $241.44M(+0.6%) |
Jun 2017 | - | $240.03M(-2.4%) |
Mar 2017 | - | $245.84M(-1.3%) |
Dec 2016 | $249.09M(+15.9%) | $249.09M(-2.9%) |
Sep 2016 | - | $256.60M(+16.6%) |
Jun 2016 | - | $220.09M(-4.8%) |
Mar 2016 | - | $231.12M(+7.5%) |
Dec 2015 | $214.95M(-406.2%) | $214.95M(+8.6%) |
Sep 2015 | - | $198.01M(+173.7%) |
Jun 2015 | - | $72.36M(-44.9%) |
Mar 2015 | - | $131.38M(-287.1%) |
Dec 2014 | -$70.20M(+141.6%) | -$70.20M(+1802.4%) |
Sep 2014 | - | -$3.69M(-168.2%) |
Jun 2014 | - | $5.41M(-105.1%) |
Mar 2014 | - | -$107.00M(+268.2%) |
Dec 2013 | -$29.06M(+404.1%) | -$29.06M(+181.6%) |
Sep 2013 | - | -$10.32M(-3.8%) |
Jun 2013 | - | -$10.73M(-853.8%) |
Mar 2013 | - | $1.42M(-2295.8%) |
Dec 2012 | -$5.77M(+9037.7%) | - |
Nov 2012 | - | -$64.80K(+1.1%) |
Aug 2012 | - | -$64.10K(+0.8%) |
May 2012 | - | -$63.60K(+0.8%) |
Feb 2012 | - | -$63.10K(+2.1%) |
Feb 2012 | -$63.10K(+4.8%) | - |
Nov 2011 | - | -$61.80K(+70.2%) |
Aug 2011 | - | -$36.30K(-39.7%) |
Feb 2011 | -$60.20K | -$60.20K |
FAQ
- What is Travere Therapeutics annual working capital?
- What is the all time high annual working capital for Travere Therapeutics?
- What is Travere Therapeutics annual working capital year-on-year change?
- What is Travere Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Travere Therapeutics?
- What is Travere Therapeutics quarterly working capital year-on-year change?
What is Travere Therapeutics annual working capital?
The current annual working capital of TVTX is $215.95M
What is the all time high annual working capital for Travere Therapeutics?
Travere Therapeutics all-time high annual working capital is $458.74M
What is Travere Therapeutics annual working capital year-on-year change?
Over the past year, TVTX annual working capital has changed by -$222.92M (-50.79%)
What is Travere Therapeutics quarterly working capital?
The current quarterly working capital of TVTX is $191.71M
What is the all time high quarterly working capital for Travere Therapeutics?
Travere Therapeutics all-time high quarterly working capital is $546.80M
What is Travere Therapeutics quarterly working capital year-on-year change?
Over the past year, TVTX quarterly working capital has changed by -$116.13M (-37.72%)